Meeting on the Mediterranean

The Cell & Gene Meeting on the Mediterranean is a two-day conference bringing together the entire cell and gene therapy community from Europe and beyond.

Join Chief Business Officer, Matthew Durdy, and a number of experienced industry executives as they look at commercial strategies from pathfinders in the industry.

Hear from Chief Executive Officer, Keith Thompson, as he debates regulating ATMPs in a post-Brexit world with Dr Ian Hudson, Chief Executive, MHRA during their fireside chat. 

And don't miss Chief Clinical Officer, Dr Jacqueline Barry, as she introduces Chimeric Therapeutics as part of the company presentations, she will be presenting the development of a novel autologous CAR-T therapy targeting CLEC14A for the treatment of patients with advanced malignancies.

Discover who we are